“Remestemcel-L has been granted Fast Track Designation and BLA Priority Review from the FDA”. Is it a new news, or we hd already known it?
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.023(1.69%) |
Mkt cap ! $1.518B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.40 | $1.35 | $1.535M | 1.119M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 66770 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 16783 | 2 |
View Market Depth
| Last trade - 10.33am 07/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |